ICCC - イミュセル (ImmuCell Corporation) イミュセル

 ICCCのチャート


 ICCCの企業情報

symbol ICCC
会社名 ImmuCell Corp. (イミュセル)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: In Vitro_In Vivo Diagnostic Substances  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 イミュセル(ImmuCell Corporation)は乳製品と牛肉産業において動物の健康・生産性に測定可能な経済的影響をもたらす科学的に実証される実用的な製品を生産する企業。同社製品「First Defense」はワクチンと牛乳タンパク質精製技術に基づいて牛の初乳から製造される。標的疾患の牛腸炎(子牛下痢症)は新生子牛に下痢と脱水を引き起こし、しばしば重篤な病気や死亡をもたらす。「First Defense」は大腸菌K99とコロナウイルス(下痢の2つの原因)に感染した子牛を対象とする、米農務省(USDA)の認可を受けた唯一の経口送達の下痢予防製品である。「First Defense」は、新生子牛が必要とするウシ抗体を供給する。「Wipe Out Dairy Wipes」は搾乳の事前に牛の乳頭位置を確認するためのナイシンとあらかじめ湿らせた生分解性ティッシュで構成される。   イミュセルは米国の乳牛用製品メ―カ―。乳牛の健康・生産性の向上につながる製品の開発、買収、製造、販売を手掛ける。乳製品・牛肉市場向けに製品を販売。製品には牛ウィルス性下痢予防の高度免疫牛初乳「ファ―スト・ディフェンス」などがある。また、潜在性乳房炎治療用にナイシンを主成分とする「マスト・アウト」を開発。本社はメイン州。   ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME.
本社所在地 56 Evergreen Drive Portland ME 04103 USA
代表者氏名 David Scott Tomsche デビットスコットトムシェ
代表者役職名 Independent Chairman of the Board
電話番号 +1 207-878-2770
設立年月日 1982年
市場名 NASDAQ Small Cap
ipoyear 1987年
従業員数
url www.immucell.com
nasdaq_url https://www.nasdaq.com/symbol/iccc
adr_tso
EBITDA EBITDA(百万ドル) -0.22340
終値(lastsale) 8.9
時価総額(marketcap) 48805179.2
時価総額 時価総額(百万ドル) 45.13108
売上高 売上高(百万ドル) 11.03330
企業価値(EV) 企業価値(EV)(百万ドル) 51.73548
当期純利益 当期純利益(百万ドル) -1.62449
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 ImmuCell Corporation revenues increased 11% to $5.9M. Net loss totaled $1M vs. income of $366K. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net loss reflects Product development expenses increase of 85% to $1.3M (expense) Interest expense increase from $83K to $202K (expense).

 ICCCのテクニカル分析


 ICCCのニュース

   Portland-based ImmuCell reports increased revenue, net loss for second quarter  2020/08/13 15:36:40 Portland Press Herald
The bovine health products maker reported sales of $3 million and a net loss of $766,000 for the quarter ending June 30.
   ImmuCell : Corporate Presentation | MarketScreener  2020/08/12 21:13:08 MarketScreener
ImmuCell Corporation Investor Presentation August 2020 … | August 12, 2020
   ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020  2020/08/12 20:05:00 GlobeNewswire
PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
   ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020  2020/08/06 12:00:00 GlobeNewswire
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ET
   ImmuCell receives $500,000 loan from Maine Technology Institute  2020/06/16 20:23:57 Portland Press Herald
The Portland-based animal health company will use the funds to help increase its production capacity for one product and complete the development of another.
   Portland-based ImmuCell reports increased revenue, net loss for second quarter  2020/08/13 15:36:40 Portland Press Herald
The bovine health products maker reported sales of $3 million and a net loss of $766,000 for the quarter ending June 30.
   ImmuCell : Corporate Presentation | MarketScreener  2020/08/12 21:13:08 MarketScreener
ImmuCell Corporation Investor Presentation August 2020 … | August 12, 2020
   ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020  2020/08/12 20:05:00 GlobeNewswire
PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
   ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020  2020/08/06 12:00:00 GlobeNewswire
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ET
   ImmuCell receives $500,000 loan from Maine Technology Institute  2020/06/16 20:23:57 Portland Press Herald
The Portland-based animal health company will use the funds to help increase its production capacity for one product and complete the development of another.
   Portland-based ImmuCell reports increased revenue, net loss for second quarter  2020/08/13 15:36:40 Portland Press Herald
The bovine health products maker reported sales of $3 million and a net loss of $766,000 for the quarter ending June 30.
   ImmuCell : Corporate Presentation | MarketScreener  2020/08/12 21:13:08 MarketScreener
ImmuCell Corporation Investor Presentation August 2020 … | August 12, 2020
   ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020  2020/08/12 20:05:00 GlobeNewswire
PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…
   ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020  2020/08/06 12:00:00 GlobeNewswire
Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ET
   ImmuCell receives $500,000 loan from Maine Technology Institute  2020/06/16 20:23:57 Portland Press Herald
The Portland-based animal health company will use the funds to help increase its production capacity for one product and complete the development of another.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 イミュセル ICCC ImmuCell Corporation)

 twitter  (公式ツイッターやCEOツイッターなど)